These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 9094692)
1. Defective herpes simplex virus type 1 vectors harboring gag, pol, and env genes can be used to rescue defective retrovirus vectors. Savard N; Cosset FL; Epstein AL J Virol; 1997 May; 71(5):4111-7. PubMed ID: 9094692 [TBL] [Abstract][Full Text] [Related]
2. A new retrovirus packaging cell for gene transfer constructed from amplified long terminal repeat-free chimeric proviral genes. Takahara Y; Hamada K; Housman DE J Virol; 1992 Jun; 66(6):3725-32. PubMed ID: 1316479 [TBL] [Abstract][Full Text] [Related]
3. Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. Sena-Esteves M; Saeki Y; Camp SM; Chiocca EA; Breakefield XO J Virol; 1999 Dec; 73(12):10426-39. PubMed ID: 10559361 [TBL] [Abstract][Full Text] [Related]
4. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors. Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640 [TBL] [Abstract][Full Text] [Related]
5. A transient three-plasmid expression system for the production of hepatocytes targeting retroviral vectors. Qi P; Han J; Lu Y; Wang C; Zhu B Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):567-74. PubMed ID: 17687491 [TBL] [Abstract][Full Text] [Related]
6. Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors. Li KJ; Garoff H Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11658-63. PubMed ID: 8876192 [TBL] [Abstract][Full Text] [Related]
7. A safe packaging line for gene transfer: separating viral genes on two different plasmids. Markowitz D; Goff S; Bank A J Virol; 1988 Apr; 62(4):1120-4. PubMed ID: 2831375 [TBL] [Abstract][Full Text] [Related]
8. Cell engineering for muscle gene therapy: Extemporaneous production of retroviral vector packaging macrophages using defective herpes simplex virus type 1 vectors harbouring gag, pol, env genes. Parrish E; Peltékian E; Dickson G; Epstein AL; Garcia L Cytotechnology; 1999 Jul; 30(1-3):173-80. PubMed ID: 19003367 [TBL] [Abstract][Full Text] [Related]
9. Bovine leukaemia virus packaging cell line for retrovirus-mediated gene transfer. Ban J; First NL; Temin HM J Gen Virol; 1989 Aug; 70 ( Pt 8)():1987-93. PubMed ID: 2549178 [TBL] [Abstract][Full Text] [Related]
10. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207 [TBL] [Abstract][Full Text] [Related]
12. Co-packaging of non-vector RNAs generates replication-defective retroviral vector particles: a novel approach for blocking retrovirus replication. Joshi S; Ding SF; Liem SE Nucleic Acids Res; 1997 Aug; 25(16):3199-203. PubMed ID: 9241231 [TBL] [Abstract][Full Text] [Related]
13. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap. Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238 [TBL] [Abstract][Full Text] [Related]
14. Virofection: a one-step procedure for using replication-defective retrovirus vectors. Flamant F; Samarut J Virology; 1995 Aug; 211(1):234-40. PubMed ID: 7645216 [TBL] [Abstract][Full Text] [Related]
15. Retrovirus vectors bearing jaagsiekte sheep retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3. Rai SK; DeMartini JC; Miller AD J Virol; 2000 May; 74(10):4698-704. PubMed ID: 10775607 [TBL] [Abstract][Full Text] [Related]
16. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line. Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671 [TBL] [Abstract][Full Text] [Related]
17. Analysis of ALV-based packaging cell lines for production of contaminant defective viruses. Girod A; Cosset FL; Verdier G; Ronfort C Virology; 1995 Jun; 209(2):671-5. PubMed ID: 7778301 [TBL] [Abstract][Full Text] [Related]
18. A transient three-plasmid expression system for the production of high titer retroviral vectors. Soneoka Y; Cannon PM; Ramsdale EE; Griffiths JC; Romano G; Kingsman SM; Kingsman AJ Nucleic Acids Res; 1995 Feb; 23(4):628-33. PubMed ID: 7899083 [TBL] [Abstract][Full Text] [Related]
19. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes. Zaupa C; Revol-Guyot V; Epstein AL Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345 [TBL] [Abstract][Full Text] [Related]